CIK 0001570562
- Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461385614
- Phone
- +1 949-284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | MOATAZEDI DAVID | Sale | −105,108 | $9.04 | $950K | 499,592 |
| 2026-03-20 | MOATAZEDI DAVID | Sale 10b5-1 | −13,669 | $4.75 | $65K | 604,700 |
| 2026-03-17 | MOATAZEDI DAVID | Sale 10b5-1 | −116,720 | $4.89 | $571K | 618,369 |
| 2026-03-16 | MOATAZEDI DAVID | Exercise or conversion 10b5-1 | +67,489 | 735,089 | ||
| 2026-03-16 | MOATAZEDI DAVID | Exercise or conversion · Performance Restricted Stock Units 10b5-1 | −67,489 | 67,488 | ||
| 2026-02-17 | MOATAZEDI DAVID | Grant or award | +313,212 | 667,600 | ||
| 2026-02-17 | MOATAZEDI DAVID | Grant or award · Performance Restricted Stock Units | +626,424 | 626,424 | ||
| 2026-02-17 | MOATAZEDI DAVID | Grant or award · Stock Option (Right to Buy) | +457,541 | 457,541 | ||
| 2025-12-22 | MOATAZEDI DAVID | Sale 10b5-1 | −10,539 | $7.15 | $75K | 354,388 |
| 2025-06-16 | MOATAZEDI DAVID | Sale | −16,582 | $9.89 | $164K | 364,927 |
| 2025-06-13 | MOATAZEDI DAVID | Sale | −111,323 | $10.05 | $1.1M | 381,509 |
| 2025-05-12 | MOATAZEDI DAVID | Sale 10b5-1 | −15,787 | $9.87 | $156K | 492,832 |
| 2025-03-27 | MOATAZEDI DAVID | Sale 10b5-1 | −6,251 | $12.40 | $78K | 508,619 |
| 2025-03-18 | MOATAZEDI DAVID | Sale 10b5-1 | −103,376 | $13.26 | $1.4M | 514,870 |
| 2025-03-07 | MOATAZEDI DAVID | Grant or award | +95,399 | 618,246 | ||
| 2025-03-07 | MOATAZEDI DAVID | Grant or award · Performance Restricted Stock Units | +190,799 | 190,799 | ||
| 2025-03-07 | MOATAZEDI DAVID | Grant or award · Stock Option (Right to Buy) | +135,925 | 135,925 | ||
| 2024-12-23 | MOATAZEDI DAVID | Sale 10b5-1 | −10,502 | $10.85 | $114K | 522,847 |
| 2024-06-06 | MOATAZEDI DAVID | Exercise or conversion | +175,940 | $7.28 | $1.3M | 709,289 |
| 2024-06-06 | MOATAZEDI DAVID | Sale | −175,940 | $12.59 | $2.2M | 533,349 |
Page 1 of 3 · 59 trades